SCHEMBL8352133

SCHEMBL8352133

CC(=O)Oc1c(C)[nH]c2ccc(C)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.51
ALDH1A1 P00352 6/20 0.51
MAPT P10636 4/20 0.51
GAA P10253 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
HSD17B10 Q99714 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
GSK3B P49841 1/20 0.44
ADK P55263 1/20 0.44
KIF11 P52732 1/20 0.44
TP53 P04637 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
HTT P42858 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RECQL P46063 1/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.42
GFER P55789 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772243 0.86 GAA (0.54) KDM4EALDH1A1MAPTGAAMEN1
SCHEMBL4157986 0.83 AKR1C2 (0.57) KDM4EALDH1A1MAPTGAAMEN1
SCHEMBL11667064 0.80 GSK3B (0.54) KDM4EALDH1A1MAPTGAAMEN1
SCHEMBL8119091 0.77 ABCB11 (0.43) KDM4EALDH1A1MAPTGAAMEN1
Chlorobenzene SCHEMBL5800449 0.77 GAA (0.45) KDM4EALDH1A1MAPTGAAMEN1
SCHEMBL27768656 0.76 KDM4E (0.49) KDM4EALDH1A1MAPTGAAMEN1
SCHEMBL20398612 0.75 ABCB11 (0.53) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL30434152 0.75 ABCB11 (0.53) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL20398581 0.75 ABCB11 (0.53) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL22898798 0.75 HSD17B10 (0.50) KDM4EALDH1A1MAPTGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999032112-A1 METHOD FOR TREATING DIABETES ELI LILLY AND COMPANY (US) 1999-07-01 WO disclosed